Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
The Role of Brivaracetam in the Management of Childhood Epilepsy
Wei Jiang1,2, Feifei Xiao1, Fen Zhao3
1Department of Pediatric Neurology, Binzhou Medical University Hospital, Binzhou, China.
Abstract:
Brivaracetam (BRV) is a novel third-generation antiseizure medication characterized by its high-affinity selective binding to synaptic vesicle protein 2A (SV2A). Its pharmacokinetic profile is marked by linear and dose-proportional metabolism, low protein binding, and a low risk of drug-drug interactions, eliminating the need for dosage adjustment in cases of renal impairment. Clinical studies have confirmed its efficacy and acceptable tolerability as an adjunctive therapy for children with epilepsy. Although existing data support BRV as a valuable therapeutic option, its optimal dosing strategies and specific indications in the pediatric population warrant further investigation. This review provides a comprehensive evaluation of BRV to guide evidence-based management of pediatric epilepsy.
More Related Videos
07:01Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...